Clinical trial Recruiting at 3 sites Observational

Research on inherited heart conditions in children

Official title: Inherited Cardiac cONditions In Kids: Understanding the Genetics and Outcomes of Paediatric Inherited CardiacConditions

Run by Imperial College London · NCT05158738 · Data updated 2026-11-12

This study is trying to learn more about inherited heart conditions in children and their parents by collecting health information over five years to improve understanding and treatment.

More Cardiovascular Diseases trials

Quick facts

Study typeObservational
SexAll
Enrollment300 (estimated)
SponsorImperial College London
Academic / other
Locations3 sites (London and 2 other locations)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedMarch 5, 2025
Trial IDNCT05158738 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children under 16 years with a confirmed diagnosis of cardiomyopathy or other rare inherited cardiac conditions, along with their parents.

Probably not a fit

Patients over 16 years old or those with significant secondary causes of cardiac dysfunction are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on children diagnosed with inherited cardiac conditions, particularly cardiomyopathy, and their unaffected parents. Participants will enroll through an online platform called The Heart Hive, where they can upload their health data for research purposes. The study aims to collect genetic and clinical information over a five-year period to identify genetic variants and environmental factors that influence disease progression and treatment response. By analyzing this data, the researchers hope to enhance understanding of these rare conditions and improve patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management of inherited cardiac conditions in children.

How similar studies have gone: Other studies focusing on genetic factors in inherited cardiac conditions have shown promise, indicating that this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males or females with a confirmed diagnosis of childhood onset (\<16 years) PCM
* Males or females with childhood onset (\<16 years) of a rare inherited cardiac condition likely to be a monogenic condition
* Capacity for parents to provide informed consent
* Genotype negative following local standard diagnostic ICC gene panel
* Family members of patients with ICC, both affected and unaffected

Exclusion Criteria:

* Parents who lack capacity to provide consent on behalf of their children/themselves
* Onset over 16 years
* Significant teratogen exposure (including maternal diabetes) likely to contribute to cardiac dysfunction (following discussion with Cardiologist)
* Significant coronary heart disease likely to contribute to cardiac dysfunction (following discussion with Cardiologist)
* Other secondary causes of cardiac dysfunction likely to explain the phenotype of the patient
* Patients with a confirmed genetic diagnosis (patients with variants of uncertain significance are not excluded).

Where it's running

  • Royal Brompton Hospital
    London, United Kingdom
    Recruiting
  • Great Ormond Street Hospital for Children
    London, United Kingdom
    Recruiting
  • Harefield Hospital
    Uxbridge, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.